FBT
First Trust NYSE Arca Biotechnology Index Fund
1W: +3.2%
1M: -5.5%
3M: -7.7%
YTD: -4.4%
1Y: +16.6%
3Y: +32.5%
5Y: +24.2%
$198.57
+6.82 (+3.56%)
After Hours: $197.18 (-1.39, -0.70%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$1.2B
Holdings31
Top 10 Wt—%
Beta0.92
% Profitable71%
Coverage0%
Portfolio Valuation
P/E25.2
P/B4.3
P/S5.4
EV/EBITDA17.8
P/FCF23.0
PEG2.15
Profitability & Returns
Gross Margin81.3%
Net Margin18.5%
ROE15.4%
ROA7.6%
ROIC12.7%
Div Yield0.22%
Leverage & Liquidity
Debt/Equity0.65
Debt/Assets0.32
Net Debt/EBITDA0.7x
Interest Cov9.2x
Current Ratio2.34
Quick Ratio2.02
Growth (YoY)
Revenue+19.4%
Net Income+54.7%
EPS+55.5%
FCF+57.0%
EBITDA+47.2%
Rev CAGR 3Y+21.2%
Quality Scores
Piotroski F5.9
Altman Z9.72
IS Quality70.7
IS Overall61.9
IS Value46.3
Median P/E22.1
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 30 | 0.0% | 3.9 |
| Other | 1 | 0.0% | — |
Smart Money Overlap
3 holdings with signals
Showing 31 of 31 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Sarepta Therapeutics, Inc. | SRPT | 0.00% | $56.8M | 3,429,268 | -3.5 | $2.5B | Healthcare |
| 2 | Vertex Pharmaceuticals Incorporated | VRTX | 0.00% | $80.3M | 176,141 | 29.2 | $115.6B | Healthcare |
| 3 | Bruker Corporation | BRKR | 0.00% | $50.2M | 1,500,581 | -632.7 | $5.4B | Healthcare |
| 4 | Neurocrine Biosciences, Inc. | NBIX | 0.00% | $77.7M | 601,809 | 27.3 | $13.2B | Healthcare |
| 5 | Exelixis, Inc. | EXEL | 0.00% | $76.2M | 1,855,578 | 14.8 | $11.5B | Healthcare |
| 6 | BioMarin Pharmaceutical Inc. | BMRN | 0.00% | $75.9M | 1,386,199 | 30.6 | $10.7B | Healthcare |
| 7 | Regeneron Pharmaceuticals, Inc. | REGN | 0.00% | $75.3M | 102,592 | 17.1 | $77.9B | Healthcare |
| 8 | Corcept Therapeutics Inc. | CORT | 0.00% | $73.9M | 2,179,174 | 42.4 | $4.3B | Healthcare |
| 9 | NeoGenomics, Inc. | NEO | 0.00% | $50.6M | 6,209,626 | -1.9 | $202M | Healthcare |
| 10 | BioNTech SE (ADR) | BNTX | 0.00% | $72.8M | 818,432 | -16.7 | $22.3B | Healthcare |
| 11 | Halozyme Therapeutics, Inc. | HALO | 0.00% | $71.0M | 1,127,615 | 23.5 | $7.5B | Healthcare |
| 12 | argenx SE (ADR) | ARGX | 0.00% | $70.7M | 103,683 | 37.8 | $43.1B | Healthcare |
| 13 | Incyte Corporation | INCY | 0.00% | $70.8M | 764,648 | 14.2 | $18.4B | Healthcare |
| 14 | Natera, Inc. | NTRA | 0.00% | $70.4M | 348,766 | -129.6 | $28.0B | Healthcare |
| 15 | BeOne Medicines Ltd. (ADR) | ONC | 0.00% | $68.1M | 241,840 | 158.2 | $30.3B | Healthcare |
| 16 | Bio-Techne Corporation | TECH | 0.00% | $63.9M | 1,243,870 | 101.2 | $8.2B | Healthcare |
| 17 | Alnylam Pharmaceuticals, Inc. | ALNY | 0.00% | $63.6M | 205,179 | 138.5 | $43.6B | Healthcare |
| 18 | Veracyte, Inc. | VCYT | 0.00% | $63.4M | 1,943,805 | 39.1 | $2.6B | Healthcare |
| 19 | ACADIA Pharmaceuticals Inc. | ACAD | 0.00% | $63.0M | 3,051,470 | 9.5 | $3.8B | Healthcare |
| 20 | Genmab A/S (ADR) | GMAB | 0.00% | $61.1M | 2,385,267 | 25.4 | $16.1B | Healthcare |
| 21 | Repligen Corporation | RGEN | 0.00% | $57.4M | 489,850 | 132.2 | $6.4B | Healthcare |
| 22 | Moderna, Inc. | MRNA | 0.00% | $124.2M | 2,382,500 | -7.4 | $21.1B | Healthcare |
| 23 | Alkermes Plc | ALKS | 0.00% | $77.9M | 2,755,157 | 20.0 | $4.9B | Healthcare |
| 24 | Biogen Inc. | BIIB | 0.00% | $79.5M | 435,558 | 21.5 | $27.8B | Healthcare |
| 25 | US Dollar Private | $USD | 0.00% | $1.1M | — | — | — | — |
| 26 | Krystal Biotech, Inc. | KRYS | 0.00% | $80.3M | 312,599 | 36.0 | $7.5B | Healthcare |
| 27 | Exact Sciences Corporation | EXAS | 0.00% | $82.8M | 800,328 | -95.7 | $20.0B | Healthcare |
| 28 | Amgen Inc. | AMGN | 0.00% | $87.3M | 250,565 | 24.7 | $190.8B | Healthcare |
| 29 | United Therapeutics Corporation | UTHR | 0.00% | $88.7M | 169,063 | 18.0 | $23.7B | Healthcare |
| 30 | Gilead Sciences, Inc. | GILD | 0.00% | $94.8M | 674,832 | 20.2 | $171.6B | Healthcare |
| 31 | Illumina, Inc. | ILMN | 0.00% | $73.0M | 579,320 | 22.7 | $19.3B | Healthcare |